Clarkston Capital Partners LLC Trims Stake in Waters Co. (WAT)
Clarkston Capital Partners LLC trimmed its holdings in Waters Co. (NYSE:WAT) by 3.3% in the 4th quarter, HoldingsChannel.com reports. The fund owned 256,814 shares of the medical instruments supplier’s stock after selling 8,732 shares during the quarter. Waters comprises 1.9% of Clarkston Capital Partners LLC’s portfolio, making the stock its 19th biggest holding. Clarkston Capital Partners LLC’s holdings in Waters were worth $49,614,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also bought and sold shares of WAT. Oppenheimer Asset Management Inc. lifted its position in Waters by 0.4% in the second quarter. Oppenheimer Asset Management Inc. now owns 573 shares of the medical instruments supplier’s stock worth $105,000 after purchasing an additional 2 shares during the period. ETF Managers Group LLC bought a new position in Waters in the second quarter worth $106,000. Intellectus Partners LLC lifted its position in Waters by 4.9% in the second quarter. Intellectus Partners LLC now owns 667 shares of the medical instruments supplier’s stock worth $123,000 after purchasing an additional 31 shares during the period. Bristlecone Advisors LLC bought a new position in Waters in the third quarter worth $175,000. Finally, Advisory Services Network LLC lifted its position in Waters by 6.0% in the second quarter. Advisory Services Network LLC now owns 1,145 shares of the medical instruments supplier’s stock worth $210,000 after purchasing an additional 65 shares during the period. 92.18% of the stock is owned by institutional investors.
In other news, SVP Rohit Khanna sold 26,913 shares of the firm’s stock in a transaction on Friday, October 27th. The stock was sold at an average price of $197.93, for a total value of $5,326,890.09. Following the completion of the sale, the senior vice president now directly owns 13,677 shares in the company, valued at $2,707,088.61. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, SVP Eugene G. Cassis sold 23,863 shares of the firm’s stock in a transaction on Wednesday, December 13th. The shares were sold at an average price of $197.53, for a total value of $4,713,658.39. Following the completion of the sale, the senior vice president now owns 15,100 shares of the company’s stock, valued at $2,982,703. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 93,159 shares of company stock valued at $18,412,172. 5.07% of the stock is currently owned by corporate insiders.
Shares of Waters Co. (NYSE WAT) traded up $2.85 during midday trading on Monday, hitting $210.72. The company’s stock had a trading volume of 739,700 shares, compared to its average volume of 438,908. The company has a market capitalization of $17,010.00, a PE ratio of 31.08, a PEG ratio of 2.82 and a beta of 0.82. Waters Co. has a 12 month low of $137.72 and a 12 month high of $211.65. The company has a debt-to-equity ratio of 0.66, a quick ratio of 5.71 and a current ratio of 6.16.
Waters (NYSE:WAT) last announced its earnings results on Tuesday, October 24th. The medical instruments supplier reported $1.77 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.74 by $0.03. Waters had a return on equity of 23.61% and a net margin of 24.34%. The company had revenue of $565.58 million during the quarter, compared to analyst estimates of $555.25 million. During the same period last year, the company posted $1.57 earnings per share. The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. equities analysts forecast that Waters Co. will post 7.42 EPS for the current year.
ILLEGAL ACTIVITY NOTICE: “Clarkston Capital Partners LLC Trims Stake in Waters Co. (WAT)” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://www.watchlistnews.com/clarkston-capital-partners-llc-trims-stake-in-waters-co-wat/1818538.html.
Waters Company Profile
Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.
Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Co. (NYSE:WAT).
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.